Prof. Ehud Gazit from Tel Aviv University (TAU) was recently named as one of the recipients of this year’s Meitner-Humboldt Research Award, a prize handed by Germany to outstanding scientists based abroad.

Awarded by the Alexander von Humboldt Foundation of Germany, the prize is granted each year to up to 100 world-renowned researchers in all disciplines in recognition of their accomplishments, and is valued at 60,000 euros.

Professor Gazit is an internationally-recognized veteran researcher in the fields of nanotechnology, biochemistry and biophysics. He has registered over 100 patents and published nearly 400 peer-reviewed articles in top scientific journals. 

“I am grateful to receive international recognition for my academic research and support towards future endeavors,” said Gazit. “I would like to thank the members of the award committee and Professor Klaus Jandt from the University of Jena in Germany for the nomination and selection. This is a profound honor for me.”

Gazit is currently a professor at TAU’s Shmunis School for Biomedicine and Cancer Research in the George S. Wise Faculty of Life Sciences, and in the Department of Materials Science and Engineering in the Fleischman Faculty of Engineering. 

Additionally, he heads TAU’s Biotechnology of Degenerative Diseases project, serves as a member of the TAU’s Executive Council and as the founding director of the Blavatnik Center for Drug Discovery.

His groundbreaking research has earned him numerous accolades in Israel as well, including the Kadar Family Award for Outstanding Research, the Mifal HaPais Landau Prize and the Rappaport Prize for Excellence in Biomedical Research. In 2022, he was selected for the International Solvay Chair in Chemistry.

Gazit is a fellow in the National Academy of Inventors in the US and Royal Society of Chemistry in the UK, a member of the European Molecular Biology Organization, and a member of the National Academy of Sciences in India.